computational model
| 5 min read
The FDA announced interest in advancing drug repurposing programs across a wide variety of conditions, though challenges remain.
| 5 min read
A new model combines high-resolution experimental data with deep learning to reveal how non-coding DNA sequences control gene activity across different cell types.
| 5 min read
After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis.
| 5 min read
Studies indicate AI-enabled compound management systems can streamline workflows, reduce manual errors, and provide better visibility into experimental and predicted data.
| 3 min read
AI is reshaping early drug discovery, but persistent translational gaps, biological complexity, and validation challenges limit how far machine learning alone can predict human outcomes.
| 5 min read
Quantum-informed AI could open up unexplored chemical space, speeding the design of safer, more effective drugs.
| 1 min read
Ongoing collaboration aims to bring new treatments for neurodegenerative conditions closer to patients.
| 8 min read
Jo Varshney explains how human-relevant models and mechanistic simulations are transforming early-stage drug discovery and development.
| 5 min read
Computational models are reshaping how therapies are discovered, tested, and optimized.
| 5 min read
Regulatory science is increasingly relying on modeling, simulation, and AI tools to accelerate drug development while maintaining safety and efficacy.
